A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder.
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Etodolac/lidocaine (Primary)
- Indications Bursitis; Inflammatory pain
- Focus Registrational; Therapeutic Use
- Sponsors MEDRx
- 04 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jul 2010 New trial record